Archive April 22, 2015 Deciphera Pharmaceuticals Presents Data Highlighting Kinase Inhibitor Pipeline including Proprietary and Partnered Programs at AACR 2015 Annual Meeting
Archive April 1, 2015 Deciphera Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
Archive March 23, 2015 Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Private Company Conference Series
Archive March 18, 2015 Deciphera to Present Data on Oncology Pipeline at American Association for Cancer Research Annual Meeting 2015
Archive March 16, 2015 Deciphera Pharmaceuticals to Present at Future Leaders in the Biotech Industry Conference
Archive November 20, 2014 Deciphera Pharmaceuticals Presents Data on Altiratinib (DCC-2701), an Advanced Multi-targeted Kinase Inhibitor, at 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Archive November 17, 2014 Deciphera Pharmaceuticals Presents Data on Altiratinib (DCC-2701) that Demonstrated Inhibition of Tumor Growth and Invasion in Bevacizumab Resistant Glioblastoma
Archive May 30, 2014 Deciphera Pharmaceuticals Announces Initiation of Phase 1 Cancer Trial for Altiratinib (DCC-2701) MET/TIE2/VEGFR/TRK Kinase Inhibitor for Solid Tumors
